Immunogen (IMGN) Misses Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: H.C. Wainwright Upgrades Immunogen Inc. (IMGN) to Buy
May 6, 2019 7:06 AM EDT(Updated - May 6, 2019 7:45 AM EDT)
(updated to add analyst comment)
H.C. Wainwright analyst Debjit Chattopadhyay upgraded Immunogen Inc. (NASDAQ: IMGN) from Neutral to Buy with a price target of $7.00 (from $3.50).
The analyst comments "From current levels, we... More
